Published-Ahead-of-Print December 4, 2008, DOI:10.2164/jandrol.108.006098
Journal of Andrology, Vol. 31, No. 2, March/April 2010
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.108.006098
Estradiol and Metabolic Syndrome in Older Italian Men: The InCHIANTI Study
MARCELLO MAGGIO*,
,
FULVIO LAURETANI
,
GIAN PAOLO CEDA*,
STEFANIA BANDINELLI
,
SHEHZAD BASARIA
,||,
GIUSEPPE PAOLISSO¶,
CLAUDIO GIUMELLI*,
MICHELE LUCI*,
SAMER S. NAJJAR#,
E. JEFFREY METTER
,
GIORGIO VALENTI*,
JACK GURALNIK** AND
LUIGI FERRUCCI*
From the * Department of Internal Medicine and
Biomedical Sciences, Section of Geriatrics, University of Parma, Italy; the
Clinical Research Branch and #
Laboratory of Cardiovascular Science, National
Institute on Aging, Baltimore, Maryland; the
Tuscany Regional Health Agency, Florence,
Italy; the
Geriatric Rehabilitation Unit,
Azienda Sanitaria di Firenze (ASF)–Florence, Italy; the ||
Department of Medicine, Division of
Endocrinology, Johns Hopkins University School of Medicine, Bayview Medical
Center, Baltimore, Maryland; the ¶ Department of
Geriatric Medicine and Metabolic Diseases II, University of Naples, Italy; and
the ** Laboratory of Epidemiology, Demography, and
Biometry, National Institute on Aging, National Institutes of Health,
Bethesda, Maryland.
|
Correspondence to: Marcello Maggio, Department of Internal Medicine and
Biomedical Sciences, Section of Geriatrics, University of Parma, via Gramsci
14 43100 Parma, Italy; or Marcello Maggio or Luigi Ferrucci, National
Institute on Aging (NIA), National Institutes of Health (NIH) NIA-ASTRA unit
at Harbor Hospital, 3001 S Hanover Street, Baltimore, MD 21225 (e-mail:
marcellomaggio2001{at}yahoo.it;
ferruccilu{at}grc.nia.nih.gov). |
The increasing prevalence of metabolic syndrome (MS) with age in older men
has been linked with decreasing testosterone levels. Interestingly, while
testosterone levels decline with age, estradiol (E2) levels remain relatively
stable, resulting in a decreased testosterone:E2 ratio. Because E2 levels tend
to be elevated in morbid obesity, insulin resistance, and diabetes, it is
reasonable to hypothesize that high E2 levels are associated with MS in older
men. We studied the relationship of total and free E2 with MS after adjustment
for multiple confounders, including age, BMI, smoking, alcohol consumption,
physical activity, interleukin-6 (IL-6), fasting insulin, and testosterone.
Men 65 years or older (age range, 65–96; n = 452) had complete data on
E2, testosterone, fasting insulin, sex hormone–binding globulin, IL-6,
and albumin. Concentrations of free E2 and free testosterone were calculated
using the mass action equations. MS was defined according to Adult Treatment
Panel III (ATP-III). Participants with MS had significantly higher serum free
and total E2 (P < .001) (P = .003). After adjusting for
confounders, including age, smoking, alcohol consumption, physical activity,
log(IL-6), and log(insulin), participants with higher log(total E2) (odds
ratio [OR], 2.31; 95% confidence interval [95% CI], 1.39–4.70;
P = .02) and higher log(free E2) (OR, 2.69; 1.38–5.24;
P < .001) had an increased risk of having MS. Log(free E2)
(P = .04) maintained significant correlation with MS, even after
further adjustment for BMI. In older men, high E2 is independently associated
with MS. Whether confirmed in other studies, assessment of E2 should be also
considered in older men. Whether changes in this hormonal pattern play a role
in the development of MS should be further tested in longitudinal studies.
Key words: Androgen, andropause
This article has been cited by other articles:

|
 |

|
 |
 
K. M. Lakshman, B. Kaplan, T. G. Travison, S. Basaria, P. E. Knapp, A. B. Singh, M. P. LaValley, N. A. Mazer, and S. Bhasin
The Effects of Injected Testosterone Dose and Age on the Conversion of Testosterone to Estradiol and Dihydrotestosterone in Young and Older Men
J. Clin. Endocrinol. Metab.,
August 1, 2010;
95(8):
3955 - 3964.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2010 by The American Society of Andrology.